Dr. Timos Papagatsias’ Post

Thoughts on this? >> Merck pens pact with Pearl Bio for new biologics in cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #productmarketing #biotech #healthcare

Thoughts on this? >> MacroGenics sells rights to breast cancer drug; Rice’s new biotech accelerator >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharma #pharmaceutical #productmarketing

Thoughts on this? >> First-of-its-kind cell therapy approved by FDA for rare soft tissue cancer - BioPharma Dive >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #pharma #competitivemarketing

Thoughts on this? >> Erasca revamps pipeline, laying off staff as it licenses cancer drugs from China and nabs $160M >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #productmarketing #healthcare #biotech

Thoughts on this? >> AI-powered biologics biotech Abiologics launches with $50M backing from Flagship >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #pharmaceutical #healthcare

Thoughts on this? >> Erasca revamps pipeline, laying off staff as it licenses cancer drugs from China and nabs $160M >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #biotech #pharmaceutical

Thoughts on this? >> AI-powered biologics biotech Abiologics launches with $50M backing from Flagship >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #productmarketing #biotech

Thoughts on this? >> First-of-its-kind cell therapy approved by FDA for rare soft tissue cancer - BioPharma Dive >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #competitivemarketing #pharmaceutical #pharma

In February, the Nasdaq Biotechnology Index gained 1%, the SPDR S&P Biotech ETF spiked 12%, and the S&P Biotechnology Select Industry Index soared 16%. - Novo Nordisk’s (⬆3%) parent Novo Holdings acquired CDMO Catalent for US$ 16.5 bn. - FDA okayed Iovance Biotherapeutics, Inc.’s (⬆113%) T-cell therapy for skin cancer. - Eli Lilly and Company (⬆14%) posted a 28% increase in Q4 revenue. View our interactive dashboard: https://lnkd.in/g7miavBu Read more at: https://lnkd.in/gfpmZFyV #PipelineProspector February 2024 - Pharma & Biotech Monthly Recap by PharmaCompass.com #stockmarket #biotech #pharmaceuticalindustry #sales #pharmanews #innovation #management #digitalmarketing #technology #startups #marketing #sales #strategy #networking #Pharmaceuticals #pharmacompass

In February, the Nasdaq Biotechnology Index gained 1%, the SPDR S&P Biotech ETF spiked 12%, and the S&P Biotechnology Select Industry Index soared 16%. - Novo Nordisk’s (⬆3%) parent Novo Holdings acquired CDMO Catalent for US$ 16.5 bn. - FDA okayed Iovance Biotherapeutics, Inc.’s (⬆113%) T-cell therapy for skin cancer. - Eli Lilly and Company (⬆14%) posted a 28% increase in Q4 revenue. View our interactive dashboard: https://lnkd.in/g7miavBu Read more at: https://lnkd.in/gfpmZFyV #PipelineProspector February 2024 - Pharma & Biotech Monthly Recap by PharmaCompass.com #stockmarket #biotech #pharmaceuticalindustry #sales #pharmanews #innovation #management #digitalmarketing #technology #startups #marketing #sales #strategy #networking #Pharmaceuticals #pharmacompass